Free tool
Stocks above their 200-day average
We cover 8 companies trading above their own 200-day average. The median market value in the group is $25.27B. Across the group, the median move over the past trading day is −0.86%. Price change over the past year runs from −23.2% to +54.8% across the middle 80 percent of the group, with a median of +19.2%.
Other lists in this group
Table
8 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.